INTRODUCTION
Transposon vectors are a proven and viable alternative to viral vectors for stable gene delivery. [1] [2] [3] [4] Like integrated viruses, transposons deliver transgenes to target cells in vitro and in vivo where they are incorporated into the host genome. Unlike viruses they do not generate an immune response, they have a simpler genome, and are easier to handle. In addition, they can hold a significantly larger transgene insert than viruses, in some cases up to 100 kilobases. 5 These characteristics make transposons an attractive option for gene delivery.
PiggyBac vectors are one of the most active and flexible transposon systems available for the stable transfection of mammalian cells. 6, 7 The wild-type piggyBac transposon is 2472 base pairs in length, and is composed of two inverted minimal terminal repeats (minTRs), two internal domain sequences and a transposase-encoding domain 8, 9 ( Figure 1 , wild type). Transposase catalyzes the excision of the transposon from one DNA source (that is, a delivered plasmid) and allows its subsequent re-integration into another DNA source (that is, the host cell genome). In the majority of piggyBac vectors, the transposase gene has been removed from the transposon, replaced by transgenes of interest; the transposase is then usually delivered to the cell by a separate plasmid, a technique first demonstrated in insect cells [10] [11] [12] ( Figure 1 , delivery and helper plasmids). The minTRs and internal domains are crucial for the effective integration of the transposon into the host genome and together (known as terminal domains) consist of more than 700 base pairs each. 9, [13] [14] [15] [16] The 5 0 terminal domain also serves as a native promoter for transposase expression. During transposition, the terminal domains are integrated into the host cell genome, exclusively at TTAA integration site, alongside the delivered transgene of interest as part of the transposon. 11, 14 Therefore, like integrated viruses, they deliver a significant amount of extra DNA to the target cell genome. These sequences (the terminal domains) are required for successful transposition, but once integrated into the host cell genome, they perform no useful function. They may potentially increase the risk of cell transformation due to their retained promoter and enhancer activity, however. Attempts to reduce the size of the terminal domains to decrease this potential risk of transformation have resulted in a significant loss of transposition efficiency. 9, 13 In this paper, we describe a piggyBac vector in which most of both terminal domains have been removed from the delivery cassette without a significant loss of transposition efficiency. Only two minTR sequences remain within the delivery cassette, both of which are very short (35 base pairs for 5 0 minTR and 63 base pairs for 3 0 minTR). The expected negative effect on transposition of deleting most of the terminal domains is compensated by the presence of a transposition-incompetent piggyBac transposon containing both long terminal domains and the transposase gene within the helper part of the plasmid. This design contains two different sets of piggyBac sequences each of which has been modified to serve different functions. The working (transposable) transposon has been truncated to decrease the amount of extra DNA incorporated into the host genome, whereas the helper (nontransposable) sequence provides the long terminal domains necessary for efficient transposition of the working transposon. This design decreases the size of the required terminal domains within the delivered gene cassette from about 1500 to just 98 base pairs which significantly decreases the size of the integrated sequence within the host cell genome.
RESULTS
Full-length terminal domain sequences do not need to be in the delivered transposon for efficient transposition of piggyBac vectors We hypothesized that most of the terminal domain sequences could be moved outside of the transposon with minimal loss of transposition efficiency. To test this hypothesis, we designed several plasmids ( Figure 1 ) and determined their transposition efficiency in target cells. The first plasmid contained a delivered cassette encoding the reporter gene, red fluorescent protein (RFP), flanked by 5 0 and 3 0 minTRs (plamid-132). In a second plasmid, we inserted a wild-type piggyBac transposon separated from the RFP delivery cassette by 683 and 2466 base-pair linkers (plasmid-137, Figures 1 and 2b ). This construct allowed us to add full-length terminal domains back into the plasmid without including them within the RFP-delivered cassette. The presence of piggyBac transposase in the wild-type transposon (driven by its native promoter) eliminated the necessity of using a helper vector to deliver the transposase. A third plasmid (plasmid-185), also contained the RFP-delivery cassette, but included an additional (modified) full-length transposon in which both TTAA integration sites were mutated (to GTAA) to prevent transposition of the full-length piggyBac into the host genome. In plasmid-185, the full-length terminal domains of the second transposon were separated from the minTRs of the RFP delivery cassette by two linkers of 254 and 3354 base pairs. As the activity of the native transposase promoter is unpredictable in many mammalian cells, 17 we replaced the native promoter with an SV40 promoter in this, and subsequent, plasmids (promoters are not shown in Figure 1 , refer to Figures 2-4 for plasmid details) to more reliably drive expression of the transposase. This replacement necessitated a partial duplication of the 5 0 terminal domain to keep it intact, as both the 5 0 and the 3 0 terminal domains overlap with the transposase gene 9 (plasmid-185, Figure 2b ). Although these modifications made plasmid-185 more complicated than plasmid-137, the replacement of the native promoter with the SV40 promoter ensured predictable transposase expression and the mutation of the TTAA sites prevented the unwanted excision of the second transposon from the plasmid. Plasmid-186 (not shown in Figure 1 ) was an inactive variant of plasmid-185 that lacked a promoter for transposase expression and was used to determine the level of non-specific integration into the host cell.
We transfected Human Embryonic Kidney (HEK)-293 cells separately with each plasmid. Two days after transfection, cells were collected and RFP-positive cells isolated using flow cytometry. These cells were then monitored for RFP expression over 28 days. Initial transfection efficiency was about 90% for all plasmids. Four weeks after transfection, only 0.07% of cells initially transfected with plasmid-132 were RFP positive (Figure 2a ). Co-transfection of plasmid-132 with a helper plasmid containing only the piggyBac transposase under the control of the SV40 promoter (plasmid-200) or a plasmid carrying the entire wild-type piggyBac (p3E1.2) failed to substantially increase transposition efficiency (0.13 and 0.11%, respectively). Transfection with plasmid-137, however, resulted in a marked increase in the number of cells stably expressing RFP at 28 days to 3.89%. These results suggested that minTR alone are not sufficient to allow plasmid-to-chromatin transposition, but the presence of fulllength terminal domains elsewhere in the plasmid, even if they are located outside of the delivery cassette, will allow successful transposition into the host cell genome. Delivery of full-length terminal domains in a separate plasmid, as was shown with p3E1.2, failed to support the transposition.
These results with plasmid-137 did not clarify whether only the RFP-delivery cassette was integrated into the host cell genome or whether the entire fragment, containing both piggyBac transposons, was delivered. Therefore, we tested the integration efficiency of plasmid-185, a plasmid in which the TTAA integration sites flanking the full-length piggyBac vector in the helper part of the plasmid were mutated (to GTAA), preventing its excision from the plasmid and thus preventing its integration into the host (other modifications are described in Figure 2b ). Plasmid-185 had significantly greater transposition efficiency than plasmid-137 (13.4 versus 3.89% of initially transfected cells at 28 days) (Figure 2a) . The transposition efficiency of plasmid-186 (Figure 2) , in which the transposase promoter was deleted, was reduced to background levels (0.09%) indicating that both transposase expression and full-length terminal domains are required for successful transposition.
Partial truncation of the helper part of piggyBac plasmid yields improved transposition efficiency Although vector-185 showed relatively high integration efficiency, it was a large and complicated plasmid. Keeping the RFP delivery cassette transposon with minTRs unchanged, we tried to truncate and simplify the helper region of the plasmid to make the entire vector more compact. First we removed the complete 5 0 minTR and half of the 3 0 minTR (including both TTAA sites) from the helper transposon to disrupt the native 5 0 terminal domain promoter and prevent interaction of transposase with these terminal sequences of the helper part of the vector (plasmid-166). The SV40 promoter was then moved directly in front of the entire helper region of the plasmid to drive the transposase expression as the native promoter was disrupted and non-functional Detailed presentation of tested plasmids. All tested minimal piggyBac vectors had a delivered cassette that contained the reporter gene, RFP, flanked by 5 0 and 3 0 minTRs. Plasmid-132 contained only this RFP-delivery cassette. Plasmid-137 also had a second wild-type piggyBac transposon separated from the RFP delivery cassette by a 683 base pair linker. Plasmid-185 also had two transposons separated by a 254 base pairs linker in the same plasmid: the RFP-delivered cassette and a modified full-length transposon in which both TTAA integration sites flanking the full-length transposon, but not the RFP-delivery cassette, were mutated (GTAA) to prevent potential transposition of the full-length piggyBac into the host genome. In plasmid-185 we replaced the native promoter with an SV40 promoter to more reliably drive expression of the transposase. To keep closer distance between the RFP-delivery cassette and the helper transposon, only the minimal SV40 promoter was placed upstream of the transposase gene, while the SV40 enhancer was placed downstream. This promoter replacement necessitated a partial duplication of the 5 0 terminal domain to keep it intact, as both the 5 0 and the 3 0 terminal domains overlap with the transposase gene. We also added an additional termination triplet and synthetic polyadenylation signal in front of the SV40 promoter to terminate any production of upstream truncated transposase initiated by residual native promoter activity. Control plasmid-186 (not mentioned in Figure 1 ) was constructed similar to plasmid-185, but without the SV40 promoter. The lack of promoter prevented transposase expression while retaining all potentially important transposition sequences. This streamlined vector-166 demonstrated greater integration efficiency than vector-137 and vector-185. Thirty-two percent of the initially transfected HEK cells stably incorporated and expressed the delivered transgene (RFP) at 4 weeks ( Figure 3a) . Removing more sequences from the terminal domains of plasmid-166 (leaving a functional transposase gene, but markedly truncated terminal domains in the helper region) significantly reduced the plasmid's transposition efficiency (0.72%) (plasmid-206). The differences in transposition efficiency between plasmids 166 and 206 demonstrated that the presence of long internal domains flanking the transposase gene were required for the successful transposition of the piggyBac vector; these long internal domains could be located outside of the integrated transposon as long as minTRs were present within the delivered sequence.
Minimal transposon vector allows stable gene delivery in multiple cell types After testing multiple transposon plasmids in HEK-293 cells, we concluded that plasmid-166 had the highest transposition efficiency. As the overall goal of this project was to develop a plasmid in which most of the full-length terminal domains were removed from the RFP-delivery cassette with minimal impairment of transposition efficiency, we tested this plasmid against one in which the RFP-delivery cassette consisted of full-length terminal domains, typical of existing piggyBac vectors. Therefore, we made a piggyBac plasmid in which the RFP-delivery cassette consisted of full-length terminal domains (plasmid-210, Figures 1 and 4b ) instead of the minTRs found in plasmid-166. Similar to the design of plasmid-166, plasmid-210 also contained the transposase within the same construct under the control of the SV40 promoter. These plasmids were then tested in the following cells: HEK-293, HeLa, L929 (mouse fibroblasts) and primary rat pulmonary artery smooth muscle cells. We compared the integration efficiency of both these plasmids to that obtained with the non-transposon plasmid-211 (plasmid-211, transposon-independent integration control) and with the transposon vector-186 that had the same piggyBac sequences, but did not express transposase due to the absence of the upstream promoter.
As shown in Figure 4b , plasmid-166 and -210 were successfully transposed in all cell types studied. HEK-293 cells were the most transposable, whereas HeLa cells were the most resistant to transposition. Although plasmid-210 demonstrated higher transposition efficiency in all cell types, the differences between the two were not marked. Both plasmid-166 and -210 had significantly higher integration efficiencies than the non-transposon naked DNA control (plasmid-211) and transposase-deficient vector-186.
Stably transgene-positive target cells contain only the delivered transposase sequence The preceding results demonstrated that the long internal domains could be removed from the delivered cassette to other parts of the plasmid without significantly impairing transposition efficiency. However, the spontaneous integration of the entire plasmid, not just the transposon, might have contributed to this RFP-positivity. To prove that only the transposon, but not the entire plasmid, was integrated into the host genome of cells stably expressing RFP, we performed PCR on total cell DNA using distinct primers, one that amplified only the RFP-delivery cassette and another that overlapped with part of the non-delivered plasmid. Because the first 13 base pairs of both terminal repeats and the following TTAA integration sites plus the next 7 base pairs flanking the RFP delivery cassette in plasmid-166 (total 24 base pairs) are symmetrical, we used only one primer for each PCR reaction. The inner primer (T TAACCCTAGAAAGATA) was complementary to the common sequence located at both minTRs (single underline) and also included a TTAA integration site (double underline) to which they are flanked in the plasmid or in chromatin. The outer primer (GTCGACT T TAACCCTAGAA) straddled the sequences that transitioned between the non-delivered plasmid and the delivered transposon. This outer primer partially overlapped with the inner primer (single and double underlines). The part of the outer plasmid that coupled with the sequences within the transposon was 5 base pairs shorter when compared with the inner primer, yet covered an additional 7 base pairs fragment (dotted underline) located outside of the transposon and TTAA integration site in the plasmid. The outside 7 base pairs fragment at both sides is not transpositioned and therefore exists only in the plasmid. Therefore, if only the transposon is incorporated into the host cell genome, amplification of total cellular DNA with the outer primer will not generate a PCR product whereas amplification with the inner primer will. In contrast, if the entire plasmid had been incorporated into the host cell genome, both the outer and the inner primer will generate a PCR product. If only a part of the RFP delivery cassette had been incorporated, no PCR products would be generated with either primer.
We first demonstrated that PCR amplification of plasmid-166 with either the outer or the inner primer generated a PCR product with a similar size (Figure 5a ) and an identical rate of accumulation as confirmed by qPCR (data not shown). The complete sequence of the RFP delivery cassette in both PCR products was confirmed by sequence analysis. We then isolated DNA from: RFP-negative HEK-293 cells, cells stably expressing RFP 28 days after transfection with plasmid-166 (integrated), and HEK-293 cells that were initially RFP positive, but became RFP negative 28 days after being transfected with plasmid-166 (transiently transfected, nonintegrated). In addition, DNA from three different clones of HEK-293 cells that stably expressed RFP 65 days after initial transfection with plasmid-166, was analyzed.
As shown in Figure 5a , PCR amplification of DNA from cells stably expressing RFP (RFP( þ )) yielded a PCR product equal to the Figure 5 . (a) PCR of plasmid-166 and genomic DNA using inner (1) and outer (2) primers. DNA from RFP-negative HEK-293 cells, cells stably expressing RFP 28 days after transfection with plasmid-166 (integrated), and HEK-293 cells that were initially RFP positive, but became RFP negative 28 days after being transfected with plasmid-166 (transiently transfected, non-integrated) and DNA from three different clones of HEK-293 cells that stably expressed RFP 65 days after initial transfection with plasmid-166, was analyzed. The PCR amplification of DNA from all cells stably expressing RFP (RFP( þ )) yielded a PCR product equal to the length of the entire transposon (1656 base pairs) only when the inner primer was used. In contrast, amplification of DNA from these cells using the outer primer failed to produce a PCR product indicating that the plasmid flanking sequences were absent. Negative cells, both those that had never been transfected (RFP( À )) and those that had been transiently transfected, but were now negative after 28 days (RFP( þ / À )), demonstrated no PCR product when amplified with either the inner or the outer primer. Plasmid DNA showed PCR products with both the inner and outer primers. In contrast, amplification of DNA from these cells using the outer primer failed to produce a PCR product indicating that the plasmid flanking sequences were absent. Negative cells, both those that had never been transfected (RFP( À )) and those that had been transiently transfected, but were now negative after 28 days (RFP( þ / À )), demonstrated no PCR product when amplified with either the inner or the outer primer (Figure 5a ). Using qPCR we demonstrated a 31-fold decrease in the signal intensity with the outer primer between the DNA from a mixed population of RFP-positive cells 28 days after transfection as compared with the inner primer and normalized to the DNA from the plasmid-166 (Figure 5b ). The small, but measurable, product accumulation seen in the mixed population of RFP-positive cells (also visible in Figure 5a ) when amplified by the outer primer was likely due to either the prolonged stability of the (non-integrated) vector plasmid in transiently transfected cells or to non-specific integration of the plasmid into the host genome of a few cells. The three clones that remained RFP positive after 65 days showed no PCR product with the outer primer. Overall, these results demonstrate that only the transposon, and not the rest of the plasmid, was stably incorporated into the genome of the target cell. These results also demonstrate that the loss of fluorescence in the transiently transfected cells (RFP( þ / À )) was due to the failure of the transposon to integrate into the host genome, rather than to inactivation of the cytomegalovirus promoter controlling RFP expression.
DISCUSSION
In this report, we describe a novel piggyBac vector in which most of the sequences within the terminal domains have been removed from the delivery cassette without a significant decrease in transposition efficiency. This is achieved by including a second piggyBac sequence (modified, to make it undeliverable) in the same plasmid. This design decreases the size of the required terminal domains within the delivered gene cassette of piggyBac vectors from about 1500 base pairs 13 to just 98 base pairs, the shortest sequence that allows stable transgene integration for any viral or non-viral gene delivery system that has been described to date. By removing these sequences from the delivered gene cassette, they are no longer incorporated into the host genome. This reduction in the length of DNA sequences incorporated into the target cell genome not only decreases the risk of insertional mutagenesis, 18 but also eliminates any apparent or potential promoter or enhancer activity that the terminal domains might exert on host cell oncogenes. 17, 19 Efforts by many investigators have focused on shortening piggyBac's terminal domains to decrease the mutagenic possibility of this transposon and thus improve its safety profile. Although reductions in the size of the terminal domains were possible, this usually resulted in a marked decrease in the efficacy of transposon integration into the host genome. 9, 13 We hypothesized that although the full-length terminal domains were important for efficient transposition, they could be removed from the gene delivery cassette without losing integration efficiency as long as these domains were present somewhere within the plasmid.
We removed the internal domains from the gene delivery cassette leaving only the minTRs behind and showed that we could stably deliver genes to a number of different cell types with almost similar efficacy as piggyBac vectors with longer terminal domains. Only the minTRs and the transgene were integrated into the host genome, while both the piggyBac transposase and the full-length terminal domains in the helper region of the plasmid were subsequently degraded with the plasmid. The integrated unit included only the 35 base pairs 5 0 -end and the 63 base pairs 3 0 -end, plus the transgene. This is significantly smaller than the residual (non-essential) DNA sequences left by viral or classical transposon vectors. In addition, neither the 5 0 nor the 3 0 piggyBac minTRs contain known active promoters or enhancers, 12, 19 further improving the safety profile of these gene delivery vectors. Unlike viral vectors, transgene expression can be terminated by a strong polyadenylation signal inside the transposon providing additional protection against unwanted activation of host cell oncogenes.
This modified piggyBac plasmid is a single-plasmid system which makes the vectors potentially useful for in vivo applications. This is in contrast to many current transposon vectors which commonly use two vectors system: one to deliver the transposon and a second to deliver the transposase. 4, 6, [10] [11] [12] 20, 21 In the wild-type piggyBac transposon, sequences from both the 5 0 and the 3 0 terminal domains overlap with the transposase gene by 4300 base pairs on each end. As both the terminal domains and the transposase are needed for gene delivery we found that keeping them together in the helper part of the plasmid made the vectors more compact without a change in either transposition efficiency or transposase expression. In the classical piggyBac systems, the optimum ratio of transposase to transposon vector for transfections in two-plasmid systems may vary to obtain the best transposition efficiency. If needed, a single transposon system can be designed to retain this flexibility. For example, stronger, weaker or inducible promoters may be used to drive transposase expression depending on the amount required to optimize transposition. Moreover, our vectors can be co-transfected with an additional helper plasmid to further control such ratio. This strategy would result in a two-plasmid system to deliver the transposon yet retain the advantage of delivering a transposon that contains only minTRs. In summary, we demonstrated that although long internal domain sequences are required for the successful transposition of piggyBac vectors, they can be positioned outside of the transposon and still perform this function, something not previously demonstrated. This novel design reduces the amount of non-essential DNA incorporated into the host genome from about 1500 to 98 base pairs and does so without significantly decreasing the integration efficiency of the piggyBac vector. This reduction in non-essential DNA may decrease the risk of host cell transformation, thus making this vector safer and more attractive for use in human research. 
MATERIAL AND METHODS Materials

Cells
Rat pulmonary artery smooth muscle cells were isolated and characterized in our cell culture core. 
Vectors and delivery systems
For plasmid-132, 5 0 and 3 0 minTRs were consecutively ligated into a basic plasmid harboring prokaryotic origin of replication and ampicillin resistance gene as synthetic phosphorylated primers, forming a joined construct with two outside GTCGACT sequences containing SalI restriction enzyme site, and a single inside BclI restriction enzyme site. A cytomegalovirus promoter, turboRFP and an SV40 polyadenylation signal were added sequentially between the 5 0 and 3 0 minTRs into the BclI site yielding control plasmid-132. The plasmid harboring the wild-type piggyBac, p3E1.2 (kindly gifted by Dr A Handler 12 ), was used as a base plasmid for generating other sequences containing the transposase gene and/or piggyBac terminal domains. This plasmid was also used as a helper plasmid with native terminal domains and co-expressed with plasmid-132 in some experiments. BssHII-BclI digestion of p3E1.2 liberated a full-length wild-type piggyBac which was ligated into plasmid-132 generating a double transposon plasmid, plasmid-137. In this vector the minimal (RFP-containing) and the full-length wild-type (containing transposase) piggyBac transposons were separated by 683 and 3478 base pairs linkers.
An intermediate version of a full-length piggyBac sequence (for plasmid-185) flanked with mutated integration sites (GTAA instead of TTAA) was amplified by PCR from a p3E1.2 plasmid using a single primer GTAACCCTAGAAAGATA, which served as both the forward and reverse primer. The 5 0 BglII digestion of this PCR-amplified wild-type piggyBac in which the integration sites were mutated, produced the first part of the extended piggyBac helper sequence carrying the full-length 5 0 terminal domain for plasmid-185 and also included a copy of the first 350 base pairs fragment of the transposase gene. This fragment was cloned into plasmid-132 downstream of the RFP delivery cassette followed by a 254 base pairs linker. A synthetic polyadenylation signal and a minimal SV40 promoter were added further downstream of this sequence. The same primer, GTAACCCTAGAAAGATA, paired with the reverse primer, GCGCGCCAC CATGGGTAGTTCTTTAGACGAT, yielded a PCR product on p3E1.2 for the second part of the helper sequence carrying transposase gene (with an extra BssHII restriction site and a KOZAK sequence upfront) overlapped with the full-length 3 0 terminal domain. This part was then cloned downstream of the minimal SV40 promoter, followed by a synthetic polyadenylation signal and a SV40 enhancer to complete plasmid-185. The linker between the 3 0 terminal domain of the helper part and the 5 0 minTR of the minimal transposon was 3354 base pairs and included the synthetic polyadenylation signal, SV40 enhancer, prokaryotic origin of replication and ampicillin resistance gene. The lengths of both linkers between the transposable and the helper parts (254 and 3,354 base pairs) were the same in plasmids 185, 186, 166, 206 and 210.
Plasmid-186 (shown in Figure 2 only) was constructed similar to plasmid-185 but lacked both the SV40 minimal promoter and enhancer. Digestion of the original wild-type piggyBac plasmid p3E1.2 with SphI and BsiWI, followed by blunting of the fragment with DNA polymerase I (Klenow) resulted in a piggyBac sequence lacking an entire 5 0 minTR and half of the 3 0 minTR for the helper part of plasmid-166. The 254 base pairs linker and the entire piggyBac helper part of plasmid-185 were replaced with a minimal SV40 promoter and the SphI-BsiWI truncated fragment of the wild-type piggyBac transposon to complete plasmid-166. As the native transposon promoter activity in plasmid-166 was disrupted, a minimal SV40 promoter was placed upstream of the entire helper part to drive transposase expression with extended un-translated sequence. This made the helper part of the plasmid smaller and eliminated the need for both the duplication of the 5 0 terminal domain and the inclusion of an extra polyadenylation signal to terminate expression of the truncated transposase (as was necessary for plasmid-185). A minimal SV40 promoter also served as a 248 base pairs linker between the RFP delivered cassette and the helper sequence.
PCR amplification on plasmid p3E1.2 using the forward primer GCCCGTCTAGATTAGTCAGTCAGAAACAACTTT and the reverse primer ATGCGCGCCACCATGGGTAGTTCTTTAGACGAT resulted in the piggyBac transposase gene fragment for plasmids 206 and 210 beginning with a BssHII restriction site and the KOZAK sequence and ending with a stop codon and a XbaI restriction site at the 3 0 end. For plasmid-206 the piggyBac transposase gene was cloned into plasmid-166 by replacing the SphI-BsiWI truncated helper fragment. SalI deletion of the transposable minimal piggyBac unit from plasmid-206 resulted in a separate helper plasmid (plasmid-200) expressing transposase which in some experiments was co-transfected with plasmid-132.
Another intermediate version of the full-length piggyBac flanked with normal (TTAA) integration sites and SalI restriction enzyme sites was PCR amplified from the p3E1.2 plasmid using a single primer TATGTCGACTT TAACCCTAGAAAGATA. This outermost sequence was identical to the flanking sequences of the RFP delivery cassette in all double transposon vectors and represents the site at which the delivered transposon and the non-delivered plasmid fragments join. The 5 0 SalI-BglII digestion of this product produced the 5 0 terminal domain for the transposable part of plasmid-210. The 3 0 PstI-SalI digestion of the same sequence liberated the 3 0 terminal domain for the transposable part of plasmid-210. Replacing the minTRs in the transposable part of plasmid-206 with full-length terminal domains resulted in plasmid-210. Plasmid-210 also contained the transposase gene under the control of the SV40 promoter in the helper region similar to plasmid-206.
All PCR products used for vector construction were sequenced to eliminate possible errors in amplified fragments.
Quantitative PCR
Total DNA was isolated from cells using the DNeasy Blood and Tissue kit (Qiagen, Hilden, Germany; Cat. No. 69504). Identical sequences at both internal ends of the RFP delivery cassette of the vector-166 as well as their flanking (non-delivered) regions in the plasmid allowed us to use a single PCR primer with either inner or outer primers. The inner primer (TTAACCCTAGAAAGATA) was complementary to the terminal sequence of the transposon and also included the flanking TTAA integration site. The outer primer (GTCGACTTTAACCCTAGAA) straddles the TTAA integration sequence that is incorporated as part of the integrated transposon and a GTCGACT sequence that is present in the original vector, but is not incorporated into the host genome. Both primers generated a nearly identical product when tested on plasmid DNA. Differences in their ability to generate a PCR product on harvested chromatin was used to determine the integration efficiency of the transposon vector-166 by iScript SYBR Green RT-PCR kit (Bio-Rad, Hercules, CA, USA; Cat. No. 170-8893, Figure 5b ). Regular PCR was used to show specificity of each qPCR reaction (Figure 5a ). Hi-Lo DNA Markers from Minnesota Molecular, Inc. (Cat. No. 1010, Minneapolis, MN, USA) were used to identify the size of PCR products. DNA sequence analysis of all PCR products was done using multiple primers matching the internal parts of the working transposon.
Flow cytometry analysis
Cells were transiently transfected with corresponding plasmids (each expressing turboRFP with excitation/emission of 553/574 nm) using FuGENE 6 or FuGENE HD as transfection reagents. Forty-eight hours after transfection, the cells were harvested by 0.05% trypsin/0.53 mM EDTA digestion, washed and re-suspended in cultured medium. RFP-expressing cells were sorted by BD Biosciences FACSAria cell sorter. Selected cells were re-seeded and the percentage of RFP-positive cells monitored for up to 28 days using BD Biosciences FACCantoII cell analyzer in the University of South Alabama Flow Cytometry Core.
Statistical analysis
Data are expressed as mean±s.e. Changes in percentage of RFPexpressing cells and qPCR data were compared using ANOVA combined with Fisher post hoc analysis, with a P-value o0.05 considered significant.
